AnaptysBio's GAAP loss for 2021 was $57.796 million, up 2.9 times from $19.931 million in the previous year. Revenue decreased 15.8% to $63.175 million from $75 million a year earlier.
AnaptysBio's GAAP loss for 2021 was $57.796 million, up 2.9 times from $19.931 million in the previous year. Revenue decreased 15.8% to $63.175 million from $75 million a year earlier. 
ir.anaptysbio.com
English (US) 